The populations of group B streptococcus (GBS) associated with vaginal carriage in pregnant women and invasive neonatal infections in Portugal were compared. GBS isolates were characterized by serotyping, pulsed-field gel electrophoresis (PFGE) profiling, and multilocus sequence typing (MLST). Serotypes III and V accounted for 44% of all colonization isolates (n ‫؍‬ 269), whereas serotypes III and Ia amounted to 69% of all invasive isolates (n ‫؍‬ 64). Whereas serotype Ia was associated with early-onset disease (EOD), serotype III was associated with late-onset disease (LOD). Characterization by PFGE and MLST identified very diverse populations in carriage and invasive disease. Serotype Ia was represented mainly by a single PFGE cluster defined by sequence type 23 (ST23) and the infrequent ST24. In contrast, serotype III was found in a large number of PFGE clusters and STs, but a single PFGE cluster defined by ST17 was found to be associated with invasive disease. Although serotype III was associated only with LOD, ST17 showed an enhanced capacity to cause both EOD and LOD. Our data reinforce the evidence for enhanced invasiveness of ST17 and identify a lineage expressing serotype Ia capsule and represented by ST23 and ST24 as having enhanced potential to cause EOD.
Streptococcus agalactiae, or group B streptococcus (GBS), emerged during the 1960s as an important cause of neonatal disease, and by the 1970s, it was already established as a leading cause of infections in the newborn (19, 21, 30) . In neonates and infants, GBS disease is defined as either early-onset disease (EOD) (age, 0 to 6 days) or late-onset disease (LOD) (age, 7 to 90 days) (10) . EOD is associated with the presence of GBS in the vagina of the mother, and transmission is thought to occur vertically through aspiration of infected amniotic fluid or passage through the birth canal. Several studies have documented the serotypes of isolates colonizing the vaginas of pregnant women and those causing invasive infections in newborns (18, 27, 30, 36) . The source of bacterial strains causing LOD is less well understood and may involve community or nosocomial acquisition, although there is also evidence that in some infants with LOD, the GBS causing the infection shares the same serotype as the GBS isolated from their mothers, suggesting a maternal source (30) .
Although, prevention of GBS neonatal infections by antimicrobial prophylaxis was suggested as early as the mid 1960s and a selective screen for carriage in pregnant women was also proposed a few years later (19) , it was not until 1996 that guidelines for the prevention of GBS neonatal infections were published in the United States (10) . The initial guidelines suggested a mixed risk-based and screening-based approach, but later guidelines suggested the universal screening of pregnant women for GBS vaginal colonization at 35 to 37 weeks of gestation and the administration of intrapartum antibiotics to carriers (9) . The implementation of these guidelines resulted in a massive decrease in EOD but has not affected the rate of LOD (8) . Moreover, it was also noted that antimicrobial prophylaxis could have unwanted long-term effects due to increased antimicrobial use (31) , and alternative prevention strategies have focused on the development of vaccines. Vaccine formulations based on the conjugation of GBS capsular polysaccharides to tetanus toxoid have already undergone phase I and II clinical trials, and studies evaluating their potential impact in the management of GBS disease suggest that vaccination may provide additional benefits over antimicrobial prophylaxis, especially due to the expected reduction in LOD (34) . As an alternative or complement to these conjugate vaccines, efforts have been directed toward identifying bacterial surface proteins that could be used in vaccination (26) .
To supplement these approaches, the genetic lineages responsible for neonatal infections and vaginal colonization were characterized, with the objective of identifying particularly virulent clones. Recent studies have relied on multilocus sequence typing (MLST) and have identified a serotype III lineage defined by sequence type 17 (ST17), of bovine origin, as having enhanced virulence (3, 23) . However, these comparative studies have been carried out in only two geographic areas (3, 4) , and it would be of interest to perform these studies in other regions, where GBS disease may present different characteristics, to test the global validity of these findings.
We undertook the characterization of GBS isolates recovered from vaginal carriage in pregnant women screened at 35 to 37 weeks of gestation and isolates responsible for invasive infections in infants in Portugal with the aim of identifying particular genetic lineages with enhanced virulence. The overrepresentation of serotype III, ST17, among neonatal invasive isolates was confirmed, and this lineage was responsible for almost half of the cases of LOD. In contrast, a lineage expressing serotype Ia and presenting ST23 and ST24 was also found to have enhanced virulence but was mainly associated with EOD.
MATERIALS AND METHODS
Bacterial strains. GBS carriage isolates (n ϭ 269) were recovered from vaginorectal swabs of healthy asymptomatic women in their last trimester of pregnancy, using the recommended procedures for enhanced recovery of GBS (9) . (16) . The laboratories were asked to submit all nonduplicate GBS isolated from normally sterile sites. Whenever isolates were available from blood and CSF of the same patient, only the CSF isolate was included in the study. Isolates were identified to the species level by Gram stain, colony morphology, catalase test, and a commercial latex agglutination technique (Slidex Strepto B; bioMérieux).
Serotyping, PFGE, and MLST. Capsular serotyping was done by slide agglutination using sera for types Ia, Ib, and II to VIII (hemolytic streptococcus typing antisera for group B; SEIKEN, Japan) according to the instructions of the manufacturer. Preparation of genomic DNA for pulsed-field gel electrophoresis (PFGE) analysis was done as described elsewhere (16) . After digestion with SmaI (Fermentas, Vilnius, Lithuania), the fragments were resolved by PFGE as described previously (16) . Comparison of PFGE patterns was performed by using Bionumerics software (Applied-Maths, Sint-Martens-Latem, Belgium) to create unweighted-pair group method with arithmetic means dendrograms. The Dice similarity coefficient was used with optimization and position tolerance settings of 1.0 and 1.5, respectively. Clones were defined as groups of isolates (n Ն 3) presenting profiles Ն80% related on the dendrogram, as previously described for Streptococcus pneumoniae (33) . The choice of this cutoff value for the definition of clones is supported by prior work on other streptococcal species showing that this value minimized incorrect classifications due to the inherent variability of the PFGE analysis (6) and that the groups defined showed extensive concordance with those defined by visual classification systems (35) , as well as with those defined using other typing methods (6, 7) .
The characterization by MLST of selected isolates was performed as described previously (22) . At least one isolate of each PFGE clone was characterized by MLST. In larger PFGE clones, isolates representing both colonization and infection, and also the different serotypes grouped in the same PFGE cluster, were characterized by MLST. Whenever an invasive isolate of a particular serotype was not grouped into a PFGE clone, the isolate was characterized by MLST. eBURST software (14) and the entire GBS MLST database (http://pubmlst.org /sagalactiae/) were used to define relationships between STs. A recently described framework was used to analyze the relationships between the results of the typing methods (7). Fisher's exact test (two tailed) was used to test associations, and a P value of Ͻ0.050 was considered significant.
Estimation of the invasiveness of serotypes and PFGE-defined clones.
In order to compare the probability of invasive disease due to individual serotypes and clones, empirical odds ratios (OR) and 95% confidence intervals (CI) were calculated by reference to all other serotypes and clones, as previously described (5) . The OR was calculated as follows: OR ϭ (ad)/(bc), where a is the number of invasive A serotypes or clones, b is the number of carriage A serotypes or clones, c is the number of non-A serotypes or clones, and d is the number of carriage non-A serotypes or clones. It follows from the formula that it is not possible to calculate an OR value when none of the isolates of a given serotype or clone is recovered from invasive infections or carriage. The choice of using all other serotypes and clones to measure the reference OR was substantiated by prior studies (reference 5 and references therein) that also provide a discussion of the strengths of this method.
RESULTS

Capsular serotyping.
The results of serotyping the 64 invasive GBS isolates from infants and the 269 isolates from asymptomatic colonization of pregnant women recovered in the last trimester of pregnancy are summarized in Table 1 . Serotypes III and V were the most prevalent among asymptomatic-colonization isolates, together accounting for 44% of all colonization isolates, whereas serotypes Ia and III were the most prevalent among invasive-disease isolates, together accounting for 69% of the isolates. There were more isolates recovered from the CSF in cases of LOD (n ϭ 6) than in EOD (n ϭ 3), but the difference was not significant (Fisher's exact test, P ϭ 0.051). Serotype III was found to be more frequently isolated from CSF than expected from its representation in invasive isolates (Fig. 1) , with seven isolates recovered from CSF (Fisher's exact test, P ϭ 0.025).
PFGE and MLST. A total of 225 isolates were analyzed by PFGE, including all isolates expressing capsular types III (n ϭ 85) and Ia (n ϭ 60); all infection isolates from the remaining serotypes and three randomly chosen colonization isolates for each invasive-infection isolate expressed these serotypes. The clones defined by PFGE are represented in Fig. 1 . To further characterize the genetic lineages associated with each PFGE clone, selected isolates (n ϭ 75) were characterized by MLST. Six novel alleles (adhP58, pheS25 and -26, atr37, glnA36, and glcK30) and seven novel STs (ST286, ST288 to ST291, ST293, and ST295) were identified among the studied isolates. Each PFGE cluster was composed mostly of isolates of the same serotype-Wallace index, 0.865, meaning that only 1 out of every 10 pairs of isolates grouped together by PFGE will not share the same serotype-but each serotype could be clearly Estimation of the invasiveness of serotypes and PFGE-defined clones. The OR were calculated for all serotypes identified among invasive isolates, and the results are presented in Table 1 . The distribution of the capsular serotypes between EOD and LOD was not homogeneous. To test if the enhanced invasiveness of some serotypes was correlated with an association with each of the disease manifestations, the OR were also calculated by comparing the isolates recovered from vaginal colonization and EOD and LOD separately, and the results are also summarized in Table 1 . The two serotypes with higher OR for disease (Ia and III) were found to have solely higher and significant OR for EOD and LOD, respectively. The majority of isolates of serotype Ia were clustered together in the same PFGE group (cluster A) but presented three distinct STs (ST23, ST24, and ST144); however, they are at most doublelocus variants of each other and belong to the same eBURST group (Fig. 1) . In contrast, isolates presenting serotype III were found in various PFGE clusters, the two larger ones clearly distinguishing the ST17 lineage (cluster B) and the ST19 lineage (cluster C). The majority of the serotype III isolates responsible for invasive disease were found in the ST17 lineage (n ϭ 19/26). Isolates causing infection belonged more frequently to this lineage than to any other lineage found within serotype III (Fisher's exact test, P ϭ 0.0003). To further explore the invasive potential of this lineage, we calculated the OR for the PFGE cluster exhibiting ST17 against all other isolates, assuming that none of the isolates expressing serotypes other than III would present this ST. We believe this to be a reasonable assumption, since no such isolates have been described in the literature to date. An enhanced invasive-disease potential was found for ST17 for both EOD (OR ϭ 4.63; 95% CI, 1.95 to 10.98) and LOD (OR ϭ 10.59; 95% CI, 4.10 to 27.34). A similar approach for the PFGE cluster with isolates presenting ST23 and ST24 showed an enhanced EOD potential (OR ϭ 2.23; 95% CI, 1.08 to 4.62), but not for LOD (OR ϭ 2.05; 95% CI, 0.80 to 5.23).
DISCUSSION
Similar to previous studies, we found a diverse population among GBS colonization isolates, as well as among those causing invasive disease in Portugal, not only in terms of capsular polysaccharides, but also in genetic lineages defined by both PFGE and MLST (Table 1 and Fig. 1 ). Apart from serotypes VI and VIII, all other serotypes were found among our collection, and all except serotype VII were associated with both carriage and infection. Among the isolates causing infection, two isolates were identified expressing serotype IV, a serotype frequently associated with carriage in Asia (1) but infrequently found as a cause of neonatal infections in Western countries (29) . Also noteworthy was the high prevalence of ST24 found exclusively among isolates of PFGE cluster A (n ϭ 7/18 isolates characterized by MLST). ST24 was described in the publication proposing the GBS MLST scheme in a single isolate of serotype Ia (22) but has rarely been found among large collections of GBS isolates characterized by MLST since then; for instance, only 1.9% of 369 isolates, including both colonization and infection isolates, recovered in the Oxford region presented ST24 (23) . None of the PFGE clones with Ն5 isolates could be solely associated with colonization or infection (Fig.  1 ), indicating that all major lineages are capable of both asymptomatic colonization and causing invasive disease. The isolates belonging to each serotype were dispersed in a widely variable number of PFGE clusters, from only 2 in serotype Ia to 19 in serotype III isolates.
When the population associated with carriage and the one causing infection were compared, serotypes Ia and III were found to have increased invasive-disease potential. On the other hand, nontypeable isolates, frequently representing variants that express little or no capsular polysaccharide, which is an important GBS virulence factor (32), showed a lowered invasive-disease potential. However, there was a clear asymmetry in the prevalence of the various serotypes in EOD and LOD, and a more detailed analysis, stratified by early and late-onset infections, indicated that serotype Ia had a significant OR for EOD while serotype III was significant only in LOD. Serotype III was also overrepresented in isolates recovered from the CSF, in agreement with previous studies suggesting an association of this serotype with meningitis (20) . A higher proportion of LOD caused by serotype III is not unusual, and several reports, both from Europe (2, 13, 37) and from the United States and Canada (11, 20) , have documented the prominent roles of serotypes Ia and III in EOD and LOD, respectively. None of these reports, however, offered data regarding serotype prevalence in vaginal colonization, preventing   FIG. 1 . PFGE, MLST, and sources of the isolates analyzed in this study. Shown is a dendrogram from the PFGE SmaI macrorestriction profile analysis of 225 isolates from neonatal invasive infections and vaginal carriage in Portugal. Unweighted-pair group method using average linkages and the Dice coefficient (indicated as percentages in the scale above the dendrogram) were used to cluster the isolates. Each PFGE clone (defined as a group of Ն3 isolates with a Dice coefficient of Ն80%) is represented by a triangle with a size proportional to the number of isolates included in the cluster. The serotypes corresponding to the isolates are indicated, as well as the number of isolates recovered from blood or CSF or associated with vaginal colonization. In brackets are the STs that were identified in each group, and the number in parentheses following the ST indicates the number of isolates in which that particular ST was identified. an evaluation of the invasive potentials of these serotypes in these contexts. Among serotype III isolates, two main lineages were distinguished by PFGE and MLST-a PFGE cluster represented exclusively by ST17 and a PFGE cluster represented by ST19 and associated STs, with the former being significantly associated with infection. These findings are in agreement with previous suggestions that the ST17 lineage constitutes a particularly virulent lineage (4, 22, 23) and that ST19 is mostly associated with carriage (25) . The two studies that suggested an enhanced virulence potential for the ST17 lineage did not distinguish between EOD and LOD (4, 22) , but a later study in the Oxfordshire, United Kingdom, region found a significant association of the ST17 lineage with both EOD and LOD (23) .
When calculating OR, the implicit assumption is that one is comparing the distribution of serotypes in the reservoir to that of the one causing disease. A higher representation of a particular serotype or clone among the isolates causing disease can then be interpreted as a higher disease potential of that particular serotype or clone. In the case of neonatal GBS infections, the reservoir is assumed to be the asymptomatic vaginal colonization of pregnant women. Multiple lines of evidence support this assumption for EOD, including the dramatic reduction in EOD brought about by intrapartum antibiotic prophylaxis (8) ; however, the case for LOD is not so well established. A maternal source was clearly implicated in some cases of LOD, but this was associated with ingestion of contaminated breast milk and not with vaginal colonization (17) , while in other cases a maternal source seems to be excluded due to negative vaginal and rectal colonization (24) . Nosocomial acquisition of GBS was shown to occur (12, 28) and to be a possible cause of LOD (24) , but its prevalence remains unknown, as well as the ultimate source of these isolates. Colonization of the human host is not restricted to the vagina and gastrointestinal tract but was also shown to occur in the upper respiratory tract, which could also be an important reservoir for GBS (15) and a significant source for transmission of these bacteria to infants. These data argue for caution when interpreting OR calculated by including isolates causing LOD.
Since serotype III showed only a significantly enhanced potential to cause LOD but was also a serotype including a large number of distinct clones, we calculated the OR for the PFGE cluster exhibiting ST17 against all other isolates. An enhanced invasive-disease potential of ST17 for both EOD and LOD was found, confirming a previous report (23) but in contrast to the results obtained when all serotype III isolates were considered (Table 1) . A similar approach for the PFGE cluster with isolates presenting ST23 and ST24 showed an enhanced EOD potential, but not for LOD, in line with the results for serotype Ia, as expected from the genetically homogeneous nature of this serotype in our collection.
The characteristics of GBS associated with carriage and responsible for invasive neonatal infections in Portugal were similar to those of comparable populations from different geographic areas. Our data identified the genetically homogeneous serotype Ia as having enhanced potential to cause EOD and confirmed the identification of the ST17 lineage, expressing serotype III, as having enhanced potential to cause both EOD and LOD, although the interpretation of the values for LOD warrants caution due to the uncertain nature of the reservoir for these infections. Most prior studies did not distinguish between EOD and LOD for the calculation of OR, and this may have prevented the identification of the enhanced potential of serotype Ia clones to cause EOD. The unusually high proportion of ST24 isolates among serotype Ia found in our collection may also have influenced the recognition of an enhanced capacity of this serotype to cause EOD, since prior studies did not find ST23 to be particularly virulent (23) . Similar to the way in which the case for enhanced invasive-disease potential of ST17 was strengthened by the independent study of geographically separated populations, the propensity of serotype Ia to cause EOD should be evaluated elsewhere.
